Apolipoproteins and Lipoproteins in Health and Disease 2.0-Reference-Cited by-同舟云学术

Apolipoproteins and Lipoproteins in Health and Disease 2.0

Published:2024-06-04 Issue:11 Volume:25 Page:6183
ISSN:1422-0067
Container-title:International Journal of Molecular Sciences
language:en
Short-container-title:IJMS

Author:

Rotllan Noemi¹²^ORCID,Escolà-Gil Joan Carles¹²^ORCID

Affiliation:

1. Institut de Recerca Sant Pau, 08041 Barcelona, Spain

2. CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain

Abstract

Cardiovascular diseases (CVDs) remain the leading cause of mortality worldwide, accounting for 32% of global deaths, according to the World Health Organization (WHO) [...]

Funder

Ministerio de Ciencia, Innovación y Universidades as well as from the Agencia Estatal de Investigación

Publisher

MDPI AG

Link

https://www.mdpi.com/1422-0067/25/11/6183/pdf

Reference9 articles.

1. Candás-Estébanez, B., Fernández-Cidón, B., Corbella, E., Tebé, C., Fanlo-Maresma, M., Esteve-Luque, V., Salas-Salvadó, J., Fitó, M., Riera-Mestre, A., and Ros, E. (2024). The Impact of the Mediterranean Diet and Lifestyle Intervention on Lipoprotein Subclass Profiles among Metabolic Syndrome Patients: Findings of a Randomized Controlled Trial. Int. J. Mol. Sci., 25.

2. García-Rodríguez, S., Espinosa-Cabello, J.M., García-González, A., González-Jiménez, E., Aguilar-Cordero, M.J., Castellano, J.M., and Perona, J.S. (2024). Interplay of Postprandial Triglyceride-Rich Lipoprotein Composition and Adipokines in Obese Adolescents. Int. J. Mol. Sci., 25.

3. Peña-De-La-Sancha, P., Muñoz-García, A., Espínola-Zavaleta, N., Bautista-Pérez, R., Mejía, A.M., Luna-Luna, M., López-Olmos, V., Rodríguez-Pérez, J.M., Fragoso, J.M., and Carreón-Torres, E. (2023). Eicosapentaenoic and Docosahexaenoic Acid Supplementation Increases HDL Content in n-3 Fatty Acids and Improves Endothelial Function in Hypertriglyceridemic Patients. Int. J. Mol. Sci., 24.

4. Bonilha, I., Gomes, É.I., Carmo, H.R., Breder, I., Barreto, J., Breder, J., Munhoz, D.B., Carvalho, L.S., Quinaglia, T., and Kimura-Medorima, S.T. (2024). Effect of Empagliflozin with or without the Addition of Evolocumab on HDL Subspecies in Individuals with Type 2 Diabetes Mellitus: A Post Hoc Analysis of the EXCEED-BHS3 Trial. Int. J. Mol. Sci., 25.

5. Suárez, N.M., Jebari-Benslaiman, S., Jiménez-Monzón, R., Benito-Vicente, A., Brito-Casillas, Y., Garcés, L., González-Lleo, A.M., Tugores, A., Boronat, M., and Martin, C. (2023). Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria. Int. J. Mol. Sci., 24.